These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2611135)
1. Mechanism of action of alpha interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors. Galvani DW; Cawley JC Br J Haematol; 1989 Dec; 73(4):475-9. PubMed ID: 2611135 [TBL] [Abstract][Full Text] [Related]
2. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors. Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928 [TBL] [Abstract][Full Text] [Related]
4. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors. Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165 [TBL] [Abstract][Full Text] [Related]
5. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM. Marley SB; Davidson RJ; Goldman JM; Gordon MY Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234 [TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human alpha interferon (INF) on chronic granulocytic leukaemia (CGL) clonogenic growth of bone marrow haematopoietic progenitors. Zduńczyk A; Miszta H; Dabrowski Z Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):45-50. PubMed ID: 1695182 [TBL] [Abstract][Full Text] [Related]
7. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis. Aglietta M; Stacchini A; Severino A; Sanavio F; Ferrando ML; Piacibello W Exp Hematol; 1989 Mar; 17(3):296-9. PubMed ID: 2783914 [TBL] [Abstract][Full Text] [Related]
8. Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response. Geissler D; Gastl G; Aulitzky W; Tilg H; Gaggl S; Konwalinka G; Huber C Leuk Res; 1990; 14(7):629-36. PubMed ID: 2388474 [TBL] [Abstract][Full Text] [Related]
9. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture. Sawai N; Koike K; Ito S; Okumura N; Kamijo T; Shiohara M; Amano Y; Tsuji K; Nakahata T; Oda M Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332 [TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells. Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710 [TBL] [Abstract][Full Text] [Related]
11. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units. Gronthos S; To LB; Haylock DN; Juttner CA Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568 [TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma. Papadakis V; Ferguson KF; Heller G; Kernan NA Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927 [TBL] [Abstract][Full Text] [Related]
13. Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM). Carlo-Stella C; Cazzola M; Ganser A; Bergamaschi G; Pedrazzoli P; Hoelzer D; Ascari E Blood; 1988 Oct; 72(4):1293-9. PubMed ID: 3139105 [TBL] [Abstract][Full Text] [Related]
14. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures. Robak T; Korycka A Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284 [TBL] [Abstract][Full Text] [Related]
15. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia. Nara N Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101 [TBL] [Abstract][Full Text] [Related]
16. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574 [TBL] [Abstract][Full Text] [Related]
17. [Effects of recombinant human alpha-2b and gamma interferons on bone marrow megakaryocyte progenitors (CFU-Meg) from patients with chronic myelocytic leukemia]. Tanabe Y; Dan K; Kuriya S; Nomura T Rinsho Ketsueki; 1989 Oct; 30(10):1800-5. PubMed ID: 2512397 [TBL] [Abstract][Full Text] [Related]
18. Studies of interferon as a regulator of hematopoietic cell proliferation. Raefsky EL; Platanias LC; Zoumbos NC; Young NS J Immunol; 1985 Oct; 135(4):2507-12. PubMed ID: 2411798 [TBL] [Abstract][Full Text] [Related]
19. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia. Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702 [TBL] [Abstract][Full Text] [Related]
20. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination. Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]